0001613103-23-000070.txt : 20230802 0001613103-23-000070.hdr.sgml : 20230802 20230802194351 ACCESSION NUMBER: 0001613103-23-000070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230731 FILED AS OF DATE: 20230802 DATE AS OF CHANGE: 20230802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PARKHILL KAREN L CENTRAL INDEX KEY: 0001527660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 231137616 MAIL ADDRESS: STREET 1: 1717 MAIN STREET, MC 6402 CITY: DALLAS STATE: TX ZIP: 75201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0427 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 4 1 wk-form4_1691019823.xml FORM 4 X0508 4 2023-07-31 0 0001613103 Medtronic plc MDT 0001527660 PARKHILL KAREN L 710 MEDTRONIC PARKWAY MINNEAPOLIS MN 55432 0 1 0 0 EVP & Chief Financial Officer 0 Ordinary Shares 2023-07-31 4 A 0 12535 0 A 44418 D Ordinary Shares 49859 I Jeffrey S. Parkhill 2021 Irrevocable Trust Ordinary Shares 843 I By Child #1 Ordinary Shares 843 I By Child #2 Ordinary Shares 843 I By Child #3 Performance Share Units 2023-07-31 4 A 0 31336 0 A Performance Share Unit 31336 31336 D Stock Option (Right to Buy) 87.76 2023-07-31 4 A 0 88254 0 A 2033-07-31 Ordinary Shares 88254 88254 D Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Includes 921 units acquired through dividend reinvestment since the last report filed by the reporting person. These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary. Each performance share unit represents a contingent right to receive one share of Medtronic common stock. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 31,336 shares will be issued. If maximum performance metrics are achieved, 62,672 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Vests on July 31, 2026. These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. /s/ Thomas L. Osteraas, attorney-in-fact 2023-08-02